Library.

“In acupuncture assessment for migraine, practitioners evaluate a patient's body balance using methods such as pulse reading, tongue observation, and physical examination to identify patterns of imbalance.”

The claim accurately describes standard TCM-style acupuncture assessment for migraine. Major medical and NIH-linked sources describe acupuncturists using pulse reading, tongue observation, and physical examination to identify patterns of imbalance before treatment. The main caveat is that these steps are part of traditional diagnostic practice and are not always standardized or detailed in migraine guidelines or clinical trials.

“After an initial course of acupuncture for migraine management, maintenance acupuncture sessions are typically done monthly or as needed.”

The evidence does not support monthly or as-needed maintenance acupuncture as a typical post-course schedule for migraine. Stronger sources describe the initial treatment course and possible durable benefit, but do not identify a standard maintenance frequency. Some clinics recommend monthly or flexible booster visits, yet those suggestions are individualized practice advice rather than an established norm in the medical literature.

“Acupuncture sessions for migraine treatment typically last 45–60 minutes, including consultation time.”

The core claim is supported: reputable migraine guidance says acupuncture visits commonly run about an hour and include consultation or assessment time. Shorter durations in many studies usually refer only to needle-retention time, not the full appointment. The main caveat is that “45–60 minutes” is a narrower range than the best sources directly establish, and real-world visit length varies by clinic and visit type.

“Acupuncture is used both for migraine prevention (reducing future migraine attack frequency) and for relief during an active migraine attack.”

Available evidence supports both parts of the claim. Acupuncture is well studied as a preventive option for migraine, with multiple systematic reviews showing reduced attack frequency. It has also been used during active migraine attacks in trials and some clinical settings, although the acute-use evidence is much smaller and it is not a standard first-line abortive treatment.